Immune cell membrane

The immune cell membrane is the specialized lipid bilayer that encapsulates various types of leukocytes, including T cells, B cells, macrophages, and neutrophils. It serves as a critical interface for immune surveillance, containing a dense array of surface proteins such as receptors, ion channels, and adhesion molecules that facilitate signal transduction and cell-to-cell communication (Frontiers in Immunology, 2021). In modern pharmacology, the immune cell membrane is not typically a single molecular target but rather a platform for therapeutic intervention, most notably in the development of biomimetic nanoparticles that use cell membranes to evade immune detection and improve drug delivery (Nature Nanotechnology, 2017). Drugs like antithymocyte globulin interact with the membrane by binding to a wide variety of surface antigens, leading to the depletion of immune cells in conditions like organ transplant rejection or aplastic anemia (StatPearls, 2023). Because it encompasses thousands of distinct molecules, it is considered a broad cellular component rather than a specific therapeutic target, and its dysfunction is central to the pathogenesis of autoimmune diseases, chronic inflammation, and cancer (Journal of Cell Biology, 2018). Therapeutic strategies targeting the membrane often focus on modulating its fluidity, lipid composition, or the spatial organization of its constituent proteins to alter immune signaling (Nature Reviews Drug Discovery, 2019). Safety concerns associated with targeting immune cell membranes include systemic cytokine release and severe immunosuppression due to non-specific cell depletion.

Other names

Leukocyte membraneWhite blood cell membraneLymphocyte membraneImmune cell surface

Polyclonal antibody-mediated depletion of immune cells, biomimetic drug delivery via membrane coating, and modulation of surface receptor signaling.